SonALAsense
PrivateLast Round
Grant
Dec 11, 2024
Total Funding Raised
$54.93M
Company Overview
SonALAsense is a clinical-stage biopharmaceutical company developing a non-invasive drug-device combination therapy, sonodynamic therapy (SDT), to treat recurrent glioblastoma, diffuse intrinsic pontine glioma, and other life-threatening cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SonALAsense Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
SonALAsense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 11, 2024 | ||||
| Grant | Sep 13, 2022 | ||||
| Grant | Jun 28, 2022 | ||||
| Series B | Jun 28, 2022 | ||||
| Series A | Feb 1, 2021 |
Key People
Founding team and executive leadership
SonALAsense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Keiretsu Forum | Grant |
| Gaingels | Series B |
| WRVI Capital | Series B |
| 5AM Ventures | Series B |
| TK & Partners | Grant |
| ARPA-H | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2022
$2M grant from National Cancer Institute and ARPA-H.
- Jun 28, 2022
$1.5M grant round led by TK & Partners
SonALAsense Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SonALAsense's valuation, stock price, and market status.